Prenatal diagnosis of chronic granulomatous disease (CGD) in four high risk male fetuses
暂无分享,去创建一个
A. Durandy | J. Boué | Y. Dumez | C. Marquetty | T. P. Huu | Jacques Hakim
[1] R. McGraw,et al. Application of molecular genetics to prenatal diagnosis and carrier detection in the hemophilias: some limitations. , 1985, Blood.
[2] C. Disteche,et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. , 1985, American journal of human genetics.
[3] D. Wara,et al. Prenatal diagnosis of chronic granulomatous disease. , 1984, American journal of medical genetics.
[4] S. Matsumoto,et al. Chemiluminescence of whole blood. II. Application to clinical examination of phagocytic functions of whole blood from various types of disease. , 1983, Clinical immunology and immunopathology.
[5] C. Rodeck,et al. Phorbol myristate acetate stimulated NBT test: a simple method suitable for antenatal diagnosis of chronic granulomatous disease. , 1983, Clinical and experimental immunology.
[6] P. Dri,et al. The measurement of superoxide anion production by granulocytes in whole blood. A clinical test for the evaluation of phagocyte function and serum opsonic capacity , 1983, European journal of clinical investigation.
[7] P. Newburger. Superoxide Generation by Human Fetal Granulocytes , 1982, Pediatric Research.
[8] N. Borregaard,et al. PRENATAL DIAGNOSIS OF CHRONIC GRANULOMATOUS DISEASE , 1982, The Lancet.
[9] P. Newburger,et al. Prenatal diagnosis of chronic granulomatous disease. , 1979, The New England journal of medicine.